21223 ⎘
Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen; Proteins Albumin; Keyhole limpet haemocyanin [KLH]
HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE
#2NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS
#3TREATMENT AND/OR PREVENTION OF AN INFECTION BY MONO/DIVALENT AND POLYVALENT ANTIGEN PARTICLE-MEDIATED IMMUNE RESPONSES
#4COMPOSITIONS AND METHODS FOR LINEAR AND CONFORMATIONAL SITE-SPECIFIC ANTIBODIES AND METHODS OF MAKING THE SAME
#5THERAPEUTIC OR PREVENTIVE AGENT FOR MYOCARDIAL INFARCTION, CARDIAC FIBROSIS, OR HEART FAILURE USING Htra3 AS THERAPEUTIC TARGET
#6MUTANT CALR-PEPTIDE BASED VACCINE
#7COMPOSITIONS AND METHODS FOR PREVENTING TUMORS AND CANCER
#8RE-FOCUSING PROTEIN BOOSTER IMMUNIZATION COMPOSITIONS AND METHODS OF USE THEREOF
#9ANTIBODIES AND VACCINES FOR USE IN TREATING ROR1 CANCERS AND INHIBITING METASTASIS
#10CELL-BASED VACCINES
#11PEPTIDE CONJUGATE VACCINE COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#12DNA ADJUVANT HYDROGEL-BASED PEPTIDE VACCINE, AND PREPARATION METHOD AND USE THEREOF
#13ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES
#14DEVELOPMENT OF SYNTHETIC PSEUDAMINIC ACID-BASED ANTIBACTERIAL VACCINES AGAINST ACINETOBACTER BAUMANNII
#15POLYMERIC VACCINE FOR OPIOID ADDICTION
#16METHOD OF SAFE ADMINISTRATION OF TAU PHOSPHOPEPTIDE CONJUGATE
#17POLYVALENT VACCINES AND METHODS FOR MAKING THEM
#18COMPOSITIONS AND METHODS FOR PREVENTING TUMORS AND CANCER
#19SYNTHETIC GLYCOCONJUGATE VACCINE PROTOTYPE AGAINST STREPTOCOCCUS SUIS
#20VACCINE COMPOSITIONS DEPLETING HEMATOPOIETIC GROWTH FACTORS FOR THE TREATMENT OF INFLAMMATORY DISEASES
#21Multivalent Pneumococcal Glycoconjugate Vaccines Containing Emerging Serotype 24F
#22METHODS AND MATERIALS TO TREAT NEURODEGENERATIVE DISEASE
#23Method Of Validating The Triggering Of An Immune Response To A Neoepitope Of A Tumor With T-Cells
#24METHODS OF USING SPLICING MODULATORS
#25ALBUMIN BINDING DOMAIN FUSION PROTEINS
#26VIRUS-INSPIRED COMPOSITIONS AND METHODS OF REDIRECTING PREEXISTING IMMUNE RESPONSES USING THE SAME FOR TREATMENT OF CANCER
#27Phosphorylated Polypeptide Antigen Vaccine, Preparation Method Therefor and Application Thereof
#28PEPTIDE VACCINES USABLE FOR HYPERCHOLESTEROLEMIA RELATED DISEASES
#29PATHOGEN MOIETIES AND USES THEREOF
#30CONJUGATED FUMONISIN TO PROTECT AGAINST MYCOTOXICOSIS
#31Vaccines targeting Pseudomonas aeruginosa
#32CARBOHYDRATE STRUCTURES AND USES THEREOF
#33CONJUGATED AFLATOXIN B TO PROTECT AGAINST MYCOTOXICOSIS
#34NUCLEIC ACIDS ENCODING HUMAN ANTIBODIES TO SIALYL-LEWIS A
#35ANTIBODY-MEDIATED NEUTRALIZATION OF BETA-LACTAMASES
#36HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE
#37Vaccine Compositions and Antibodies For Lyme Disease
#38DECTIN-1 (CLEC7A) SINGLE NUCLEOTIDE POLYMORPHISM AS A BIOMARKER FOR PREDICTING ANTIBODY RESPONSE WHEN USING BETA-GLUCAN AS A VACCINE ADJUVANT
#39TLR7/8 AGONISTS TO ENHANCE IMMUNE RESPONSES IN OPIOID USING INDIVIDUALS
#40Amino Acid Sequence Derived from Sars-Cov-2 and Use Thereof
#41COMPOSITIONS AND METHODS FOR LINEAR AND CONFORMATIONAL SITE-SPECIFIC ANTIBODIES AND METHODS OF MAKING THE SAME
#42Compositions and Methods for Treating Cocaine, Nicotine, and Methamphetamine Dependence
#43Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis
#44FENTANYL HAPTENS FOR THE PREPARATION OF A FENTANYL VACCINE
#45FENTANYL HAPTEN, FENTANYL HAPTEN-CONJUGATES, AND METHODS FOR MAKING AND USING
#46IMMUNOGENIC PEPTIDE FRAGMENTS OF METALLOPROTEASE ADAMTS-7 AND USES THEREOF IN ANTI-ATHEROSCLEROSIS AND RELATED DISEASES
#47CD200 inhibitors and methods of use thereof
#48TAU PEPTIDE ANTIGENS AND ANTIBODIES BINDING THERETO FOR THE TREATMENT OF TAUOPATHIES
#49ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES
#50MULTI-EPITOPIC CONSTRUCT
#51Virus-inspired compositions and methods of redirecting preexisting immune responses using the same for treatment of cancer
#52Albumin binding domain fusion proteins
#536-acetylmorphine analogs, and methods for their synthesis and use
#54Peptide fragments from filoviruses and their uses
#55TREATMENT OF ALZHEIMER'S DISEASE (AD) WITH AN ALUMINUM SALT
#56Immunotherapeutic compositions for the treatment of Alzheimer's disease
#57Engineered human extracellular DNASE enzymes
#58Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24F
#59PROTEIN-BASED THERAPY AND DIAGNOSIS OF TAU-MEDIATED PATHOLOGY IN ALZHEIMER'S DISEASE
#60HIV-1 Env fusion peptide nanoparticle carrier conjugates and their use
#61Immunotherapy against several tumors including neuronal and brain tumors
#62Methods of using splicing modulators
#63METHOD FOR INJECTABLE DELIVERY OF A THERAPEUTIC AGENT INTO A FISH EMBRYO
#64Non-integrative listeria-based vaccine and method for inducing antitumor immune response
#65Compositions and methods for preventing tumors and cancer
#66Heroin vaccine
#67Immunotherapy against several tumors including neuronal and brain tumors
#68Immunotherapy against several tumors including neuronal and brain tumors
#69Immunotherapy against several tumors including neuronal and brain tumors
#70METHODS OF ENHANCING IMMUNOGENICITY OF POORLY IMMUNOGENIC ANTIGEN-SPECIFIC VACCINES USING ORAL YEAST BETA-GLUCANS
#71Polypeptide, compositions and uses thereof
#72N-terminal epitopes in amyloid beta and conformationally-selective antibodies thereto
#73Peptide vaccines for hypercholesterolemia related diseases
#74Method of validating the triggering of an immune response to a neoepitope of a tumor with t-cells
#75CD200 inhibitors and methods of use thereof
#76Cyclic compound/peptide comprising an A-beta13-16 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-beta13-16 peptide
#77Cyclic compound/peptide comprising an A-beta15-18 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-BETA15-18 peptide
#78Compositions comprising cyclic peptides derived from an A-beta peptide
#79Dimethyl fumarate and vaccination regimens
#80Treatment of Alzheimer's Disease (AD) with an aluminum salt
#81PEPTIDE AND METHOD FOR REDUCING THE PHOSPHATE REQUIREMENT AND EXCRETION FROM FARM ANIMALS
#82Proteins and nucleic acids useful in vaccines targeting
#83Mimotopes of alpha-synuclein and vaccines thereof for the treatment of synucleinopathy
#84NUCLEIC ACIDS ENCODING HUMAN ANTIBODIES TO SIALYL-LEWIS A
#85ErbB peptide pharmaceutical and vaccine compositions and therapeutic uses thereof for cancer
#86HIV-1 Env fusion peptide immunogens and their use
#87Respiratory virus nucleic acid vaccines
#88Vaccines with higher carbohydrate antigen density and novel saponin adjuvant
#89Peptide fragments from filoviruses and their uses
#90IL-23-P19 VACCINES
#91Immunotherapeutic compositions for the treatment of Alzheimer's disease
#92Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis
#93VACCINE COMPOSITIONS
#94Nicotine nanovaccines and uses thereof
#95METHOD OF OPTIMIZING PEPTIDE IMMUNO-EPITOPE BY GLYCOSYLATION, OPTIMIZED PEPTIDE THEREOF AND ITS USE FOR CONJUGATE VACCINES
#96Carbohydrate structures and uses thereof
#97OmpA and Asp14 in vaccine compositions and as diagnostic targets
#98Vaccines targeting
#99Virus-like particles with high-density coating for inducing the expression of antibodies
#100Synthetic oligosaccharide subunits of the Psl exopolysaccharide of pseudomonas aeruginosa and uses thereof
#1012-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine analogs and methods for their synthesis and use
#102Dimethyl fumarate and vaccination regimens
#103AVATAR DENDRITIC CELLS: THE NEOANTIGEN NATURAL KILLER T-CELL CHEMO IMMUNO RADIATION COMPOSITION INDUCING IMMUNOGENIC CELL DEATH
#104OmpA in vaccine compositions and as diagnostic targets
#105TauT (taurine transporter) peptide cancer vaccine
#106Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#107Albumin variants and uses thereof
#108Therapeutic compositions and methods with cytokine signaling immunomodulators
#109Method for vaccination against a self-antigen in a human patient
#110RESPIRATORY SYNCYTIAL VIRUS VACCINE
#111Immunogenic rhinovirus peptides
#112Immunogenic peptide composition and method
#113Albumin binding domain fusion proteins
#114NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS
#115ANTIBODIES AGAINST IMMUNOGENIC GLYCOPEPTIDES, COMPOSITIONS COMPRISING THE SAME AND USE THEREOF
#1166-ACETYLMORPHINE ANALOGS, AND METHODS FOR THEIR SYNTHESIS AND USE
#117Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#118Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies
#119N-terminal epitopes in amyloid beta and conformationally-selective antibodies thereto
#120CD200 inhibitors and methods of use thereof
#121EPITOPES IN AMYLOID BETA AND CONFORMATIONALLY-SELECTIVE ANTIBODIES THERETO
#122Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#123Anti-BARF1 monoclonal antibody
#124Proteins and nucleic acids useful in vaccines targeting
#125Peptide vaccines usable for hypercholesterolemia related diseases
#126Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease
#127Multi-epitopic construct
#128OmpA and ASP14 in vaccine compositions and as diagnostic targets
#129Concurrent Chemotherapy and Immunotherapy
#130METHOD FOR TREATING IFNALPHA RELATED CONDITIONS
#131VACCINES FOR THE TREATMENT AND PREVENTION OF IGE MEDIATED DISEASES
#132Haptens of aripiprazole
#133IL-23-p19 vaccines
#134Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis
#135Compositions for preventing and/or treating an infection by an HIV-1 virus
#136Glycoconjugate vaccine for
#137Immunogenic/therapeutic glycan compositions and uses thereof
#138Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
#139Cancer immunotherapy by immune activation or immune modulation via Globo series antigens
#140Substances and methods for the use in prevention and/or treatment in Huntington's disease
#1416-acetylmorphine analogs, and methods for their synthesis and use
#142FGF-23 epitope peptides and methods of use thereof
#143Purified plasmodium and vaccine compositions
#144OmpA in vaccine compositions and as diagnostic targets
#145Protein-based therapy and diagnosis of tau-mediated pathology in Alzheimer's disease
#146Immunogenic peptide conjugate and method for inducing an anti-influenza therapeutic antibody response therewith
#147PROTEIN-CHAPERONED T-CELL VACCINES
#148Conjugation of capsular saccharides
#149Method for minimising progression of cancer in companion animals
#150Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders
#151Mucin-associated surface protein as a vaccine against chagas disease
#152VACCINES AND MONOCLONAL ANTIBODIES TARGETING TRUNCATED VARIANTS OF OSTEOPONTIN AND USES THEREOF
#153POLYPEPTIDE DERIVED FROM gp41, A VACCINE COMPOSITION COMPRISING SAID POLYPEPTIDE, AND USES FOR TREATING AN INFECTION BY AN HIV VIRUS IN AN INDIVIDUAL
#154Preparation methods for a novel generation of biological safe KLH products used for cancer treatment, for the development of conjugated therapeutic vaccines and as challenging agents
#155Vaccines for use in the prophylaxis and treatment of influenza virus disease
#156Treatments using a peptide and/or vaccine
#157Immunotherapeutic compositions for the treatment of alzheimer's disease
#158Methods of inhibiting platelet aggregation and preventing thrombosis using antibodies that bind (Na+K)-ATPase beta subunit
#159Haptens of aripiprazole
#160Treatment of alzheimer'S disease (AD) with an aluminum salt
#161Multi-functional mucosal vaccine platform
#162Influenza vaccine and therapy
#163Monoclonal antibodies that modulate immunity to MTB and enhance immune clearance
#164Peptide/β-1,3-glucan complex and production method thereof and pharmaceutical composition containing peptide/β-1,3-glucan complex
#165Dimethyl fumarate and vaccination regimens
#166Immunotherapy against several tumors including neuronal and brain tumors
#167Immunotherapy against several tumors including neuronal and brain tumors
#168Immunotherapy against several tumors including neuronal and brain tumors
#169Immunotherapy against several tumors including neuronal and brain tumors
#170Immunotherapy against several tumors including neuronal and brain tumors
#171Immunotherapy against several tumors including neuronal and brain tumors
#172SYNTHETIC OLIGOSACCHARIDES FOR MORAXELLA VACCINE
#173Vault immunotherapy
#174Mimotopes of tropomyosin for use in immunotherapy for shellfish and/or arthropod allergy
#175Immunotherapy against several tumors including neuronal and brain tumors
#176Tau peptides, anti-tau antibodies, and methods of use thereof
#177Respiratory syncytial virus vaccine
#178IMMUNOGENIC/THERAPEUTIC GLYCOCONJUGATE COMPOSITIONS AND USES THEREOF
#179DCLK1 short form specific binding agents
#180Albumin variants and uses thereof
#181Annexin II variant compositions and methods
#182Polyvalent conjugate vaccine for cancer
#183Compositions, methods and kits for eliciting an immune response
#184Glycan conjugates and methods of use thereof
#185Vaccine Compositions for Drug Addiction
#186Method to generate antibodies to ion channels
#187Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies
#188Purified plasmodium and vaccine compositions
#189Synthetic Oligosaccharide Subunits Of The PSL Exopolysaccharide Of Pseudomonas Aeruginosa And Uses Thereof
#190PCSK9 peptide combination vaccine and method of use
#191Methods for detecting infection
#192Generating peptoid vaccines
#193Methods for the development of vaccines based on oligosaccharide-oligonucleotide conjugates
#194Compositions for preventing and/or treating an infection by an HIV-1 virus
#195COMPOSITIONS AND METHODS OF TREATING FUNGAL AND BACTERIAL PATHOGENS
#1966-acetylmorphine analogs, and methods for their synthesis and use
#197Vaccine
#198METHOD FOR TREATING A beta-AMYLOIDOSIS
#199Heroin Haptens, Immunoconjugates and Related Uses
#200Anti-drug vaccines
#201Antibodies against and methods for producing vaccines for respiratory syncytial virus
#202Vaccines with higher carbohydrate antigen density and novel saponin adjuvant
#203Proteins and nucleic acids useful in vaccines targeting
#204METHOD FOR TREATING A SYNUCLEIOPATHY
#205Vaccine capable of inducing formation of antibodies directed to proprotein convertase subtilisin/kexin type 9 (PCSK9) in vivo
#206Compositions of a carbohydrate vaccine for inducing immune responses and uses thereof in cancer treatment
#207lipopolysaccharide outer core epitope
#208Compositions and methods including recombinant B lymphocyte cell line including at least one endogenous gene expressing at least one endogenous membrane immunoglobulin reactive to a first antigen and including at least one exogenously incorporated nucleic acid expressing at least one exogenous secreted immunoglobulin reactive to a second antigen
#209Globo H and related anti-cancer vaccines with novel glycolipid adjuvants
#210Peptide for reducing the phosphate requirement and excretion from farm animals
#211Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis
#212Conjugation of streptococcal capsular saccharides
#213Peptide vaccines based on the EGFRvIII sequence for the treatment of tumors
#214Compositions and methods including recombinant B lymphocyte cell line including at least one endogenous gene expressing at least one endogenous membrane immunoglobulin reactive to a first antigen and including at least one exogenously incorporated nucleic acid expressing at least one exogenous secreted immunoglobulin reactive to a second antigen
#215HYR1-derived compositions and methods of treatment using same
#216OMPA and ASP14 in vaccine compositions and as diagnostic targets
#217Reagents and methods for detecting influenza virus proteins
#218Immunogenic compounds comprising HIV GP41 peptide coupled to CRM197 carrier protein
#219Immunotherapy against several tumors including neuronal and brain tumors
#220IgE CH3 peptide vaccine
#221COMPOSITION
#222COMPOSITIONS
#223VACCINE COMPOSITIONS
#224Influenza vaccine and therapy
#225Siderophore conjugate immunogenic compositions and vaccines
#226PCSK9 peptide combination vaccine and method of use
#227Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies
#228Enhancing immunity to tuberculosis
#229Nucleic acids encoding human antibodies to sialyl-lewis
#230Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease
#231Conjugating amines
#232Synthetic toll-like receptor-4 (TLR-4) agonist peptides
#233Methods for treating kidney disease with fragments of ApoB-100
#234Methods for detecting infection
#235Immunogenic peptide conjugate and method for inducing an anti-influenza therapeutic antibody response therewith
#236Vaccine for
#237Immunogenic heat stable enterotoxin
#238Group A streptococcal M-related proteins and methods of use
#239Haptens of paliperidone
#240Systems and methods for identifying Replikin Scaffolds and uses of said Replikin Scaffolds
#241Neutralizing immunogen (NimIV) of rhinovirus and its uses for vaccine applications
#242Vaccine for a therapeutic or a prophylactic treatment of myasthenia gravis
#243CETP fragments
#244Peptide for protection of allergic respiratory disorders
#245Chemically Programmed Vaccination
#246Albumin-amyloid peptide conjugates and uses thereof
#247Proteins and nucleic acids useful in vaccines targeting
#248Targeting poly-gamma-glutamic acid to treat and related infections
#249Polyvalent conjugate vaccine for cancer
#250Compositions for detecting an infection by an HIV-1 virus
#251Method for treating IFNalpha related conditions
#252Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies
#253Respiratory syncytial virus vaccine
#254Companion animal treatments
#255Purified and vaccine composition
#256Vaccine immunotherapy
#257Purified and vaccine composition
#258Pneumococcal Serotype 6D
#259Methods for inhibiting C5a with C5a peptides coupled or fused to a carrier protein
#260Vaccines for use in the prophylaxis and treatment of influenza virus disease
#261Compositions and methods including recombinant B lymphocyte cell line including at least one endogenous gene expressing at least one endogenous membrane immunoglobulin reactive to a first antigen and including at least one exogenously incorporated nucleic acid expressing at least one exogenous secreted immunoglobulin reactive to a second antigen
#262Conjugates of surface proteins as malaria vaccines
#263Marker vaccine for classical swine fever
#264Peptide for reducing the phosphate requirement and excretion from farm animals
#265Multivalent glycopeptide constructs and uses thereof
#266Sialic acid (A-(2-6))-D-aminopyranose derivatives, synthesis methods and uses thereof
#267VACCINE COMPOSITIONS
#268METALLOPROTEINASE OLIGOPEPTIDES AND THEIR THERAPEUTIC USE
#269Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers
#270Globo H and related anti-cancer vaccines with novel glycolipid adjuvants
#271COMPOSITIONS AND USES
#272COMPOSITIONS AND USES
#273Targeting poly-gama-glutamic acid to treat and related infections
#274lipopolysaccharide outer core epitope
#275Method of vaccination for limiting articular inflammation in rheumatoid arthritis and multiple sclerosis by administering IL-23 peptides
#276Vaccine
#277Anti-drug vaccines
#278Polyvalent conjugate vaccine for cancer
#279Method to generate antibodies to ion channels
#280A-β immunogenic peptide carrier conjugates and methods of producing same
#281METHODS OF IMPROVING VACCINE IMMUNOGENICITY
#282lipopolysaccharide outer core epitope
#283An Antigenic Peptide Derived From Influenza Virus And A Method For Selecting Anti-Influenza Virus Antibody
#284Means for treating synucleinopathies
#285Anti-RSV immunogens and methods of immunization
#286STRONGLY INACTIVATED AND STILL HIGHLY IMMUNOGENIC VACCINE AND PROCESS OF MANUFACTURING THEREOF
#287Reagents and methods for detecting influenza virus proteins
#288Immunotherapy against several tumors including neuronal and brain tumors
#289Albumin-amyloid peptide conjugates and uses thereof
#290IMMUNE ADJUVANT COMPRISING ATP
#291HIV CD4 BINDING SITE BASED COVALENT IMMUNOGEN COMPOSITIONS
#292METHODS FOR INDUCING A SUSTAINED IMMUNE RESPONSE AGAINST A B-CELL IDIOTYPE USING AUTOLOGOUS ANTI-IDIOTYPIC VACCINES
#293Antibodies And Epitopes Specific To Misfolded Prion Protein
#294Prostate cancer diagnosis and treatment
#295Influenza vaccine
#296Vaccine immunotherapy
#297Purified plasmodium and vaccine compositions
#298Siderophore conjugate immunogenic compositions and vaccines
#299Antibodies for Norovirus
#300INFLUENZA VIRUS COMPOSITIONS AND METHODS FOR UNIVERSAL VACCINES